CAS: 170793-00-7; Magnesium,1-Chloro-2-Fluorobenzene-4-Ide,Bromide

该化合物是一种Grignard试剂,是一种有机合成中常见的有机磁性化合物,用于形成碳结层,这种化合物的特点是用氯和氟原子替代的苯环,有助于其反应和在各种化学反应中的潜在应用;镁原子的存在表明,它可以作为核素发挥作用,允许它与电极发生反应,形成新的碳结层;溴离子是一种反作用,稳定溶液中的红色试剂.通常,灰色试剂对湿气和空气敏感,需要无水环境加以储存和使用.它们经常用于酒精,氯酮和其他复杂的有机分子的合成.氯和氟亚化合物的独特组合可以影响化合物的电子特性和反应,使其成为合成有机化学中有价值的中间体.适当的处理和安全防范措施对于红色试剂的再活性至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号60811-18-9 4-溴-1-氯-2-氟苯 | CAS号348-60-7 4-氯-3-氟苯酚 | CAS号787585-34-6 2-氟-4-(2-甲基烯丙基)氯苯

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9861636-B2
    优先权日:2014-04-29
    标题 :Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors
    发明人:HE WEI
    权利人:HE WEI; ZHEJIANG DTRM BIOPHARMA CO LTD
    摘要:Described herein is a novel series of multi-fluoro-substituted pyrazolopyrimidine compounds or salts thereof. These compounds are Bruton's tyrosine kinase (BTK) inhibitors. These compounds may possess better BTK inhibition selectivity and pharmacokinetic properties. Disclosed herein are the synthesis methods of these compounds. Disclosed herein are novel synthesis methods of the multi-fluoro-substituted benzophenone and substituted phenoxy benzene. Also disclosed are pharmaceutical compositions comprising the BTK inhibitors described herein. The present invention also relates to pharmaceutical formulations comprising the compounds described herein as active ingredients. The present invention also includes the therapeutic methods by administering the BTK inhibitors and their formulations to treat and inhibit autoimmune disease, hypersensitivity disease, inflammatory diseases and cancer.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知